| 3.16 -0.01 (-0.32%) | 11-19 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 4.4  |
1-year : | 4.97 |
| Resists | First : | 3.76 |
Second : | 4.26 |
| Pivot price | 3.25 |
|||
| Supports | First : | 2.97 | Second : | 2.47 |
| MAs | MA(5) : | 3.2 |
MA(20) : | 3.35 |
| MA(100) : | 4.22 |
MA(250) : | 4.45 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 23.4 |
D(3) : | 24.5 |
| RSI | RSI(14): 35.7 |
|||
| 52-week | High : | 7.98 | Low : | 2.61 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ SBC ] has closed above bottom band by 29.8%. Bollinger Bands are 46.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 3.2 - 3.22 | 3.22 - 3.23 |
| Low: | 3.08 - 3.11 | 3.11 - 3.13 |
| Close: | 3.12 - 3.16 | 3.16 - 3.19 |
SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.
Wed, 19 Nov 2025
Can machine learning forecast SBC Medical Group Holdings Incorporated Equity Warrant recovery - newser.com
Wed, 19 Nov 2025
Is SBC Medical Group Holdings Incorporated a candidate for recovery play - Trade Analysis Summary & Safe Entry Point Identification - newser.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Industrials
|
|
|
Industry:
Consulting Services
|
|
| Shares Out | 103 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 89.2 (%) |
| Held by Institutions | 0.8 (%) |
| Shares Short | 97 (K) |
| Shares Short P.Month | 141 (K) |
| EPS | 0.31 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.42 |
| Profit Margin | 24.2 % |
| Operating Margin | 36.6 % |
| Return on Assets (ttm) | 15 % |
| Return on Equity (ttm) | 19.1 % |
| Qtrly Rev. Growth | -18.3 % |
| Gross Profit (p.s.) | 1.28 |
| Sales Per Share | 1.73 |
| EBITDA (p.s.) | 0.75 |
| Qtrly Earnings Growth | 302.7 % |
| Operating Cash Flow | -35 (M) |
| Levered Free Cash Flow | -9 (M) |
| PE Ratio | 9.87 |
| PEG Ratio | 0 |
| Price to Book value | 1.3 |
| Price to Sales | 1.81 |
| Price to Cash Flow | -9.37 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|